Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Fenter

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The American Journal of Managed Care|February 14, 2007
Finasteride versus dutasteride: a real-world economic evaluationThomas C Fenter, M Chris Runken, Libby Black, et al.
The American Journal of Managed Care|July 18, 2008
Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 yearsThomas C Fenter, E Anne Davis, Manan B Shah, et al.
The American Journal of Managed Care|March 23, 2006
An assessment of the diagnosed prevalence of diseases in men 50 years of age or olderMuta M Issa, Thomas C Fenter, Libby Black, et al.
The American Journal of Managed Care|March 23, 2006
The cost of treating the 10 most prevalent diseases in men 50 years of age or olderThomas C Fenter, Michael James Naslund, Manan B Shah, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The American Journal of Managed Care|February 14, 2007
Finasteride versus dutasteride: a real-world economic evaluationThomas C Fenter, M Chris Runken, Libby Black, et al.
The American Journal of Managed Care|July 18, 2008
Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 yearsThomas C Fenter, E Anne Davis, Manan B Shah, et al.
The American Journal of Managed Care|March 23, 2006
An assessment of the diagnosed prevalence of diseases in men 50 years of age or olderMuta M Issa, Thomas C Fenter, Libby Black, et al.
The American Journal of Managed Care|March 23, 2006
The cost of treating the 10 most prevalent diseases in men 50 years of age or olderThomas C Fenter, Michael James Naslund, Manan B Shah, et al.
Pageof 1